Showing results (81-90 of 128) with videos related to

Sort By:
Pageof 13
Clinical Rheumatology|February 20, 2019
Efficacy of mycophenolate mofetil in Japanese patients with systemic lupus erythematosusMai Kawazoe, Kaichi Kaneko, Zento Yamada, et al.
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|April 4, 2006
[Case of subcutaneous and mesenteric acute panniculitis with Sjögren's syndrome]Takahiko Sugihara, Rhuji Koike, Yurika Nosaka, et al.
Modern Rheumatology|January 11, 2021
Association of methotrexate use and lymphoproliferative disorder in patients with rheumatoid arthritis: Results from a Japanese multi-institutional retrospective studySuguru Honda, Ryoko Sakai, Eisuke Inoue, et al.
Japanese Journal of Clinical Oncology|July 24, 2023
Dose-escalation part of Phase I study of single-agent mosunetuzumab in Japanese patients with relapsed/refractory B-cell non-Hodgkin lymphomaWataru Munakata, Koji Izutsu, Yuko Mishima, et al.
Arthritis Research & Therapy|March 14, 2020
Identification of molecules associated with response to abatacept in patients with rheumatoid arthritisWaka Yokoyama-Kokuryo, Hayato Yamazaki, Tsutomu Takeuchi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 10, 2020
Efficacy and Safety of E6011, an Anti-Fractalkine Monoclonal Antibody, in Patients With Active Rheumatoid Arthritis With Inadequate Response to Methotrexate: Results of a Randomized, Double-Blind, Placebo-Controlled Phase II StudyYoshiya Tanaka, Tsutomu Takeuchi, Hisashi Yamanaka, et al.
Modern Rheumatology|May 11, 2016
The growth factor midkine may play a pathophysiological role in rheumatoid arthritisEmiko Shindo, Toshihiro Nanki, Natsuko Kusunoki, et al.
Modern Rheumatology|January 21, 2023
Long-term evaluation of E6011, an anti-fractalkine monoclonal antibody, in patients with rheumatoid arthritis inadequately responding to biological disease-modifying antirheumatic drugsYoshiya Tanaka, Tsutomu Takeuchi, Hisashi Yamanaka, et al.
Modern Rheumatology|January 11, 2021
A phase 2 study of E6011, an anti-Fractalkine monoclonal antibody, in patients with rheumatoid arthritis inadequately responding to biological disease-modifying antirheumatic drugsYoshiya Tanaka, Tsutomu Takeuchi, Hisashi Yamanaka, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|December 13, 2016
A sphingosine 1-phosphate receptor agonist ameliorates animal model of vasculitisChie Miyabe, Yoshishige Miyabe, Takaki Komiya, et al.
Pageof 13